Quince Therapeutics, Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
27.24
-4.49 (-14.15%)
Oct 12, 2026, 12:01 PM EDT - Market open
Quince Therapeutics Employees
Quince Therapeutics had 38 employees as of December 31, 2025. The number of employees increased by 2 or 5.56% compared to the previous year.
Employees
38
Change (1Y)
2
Growth (1Y)
5.56%
Revenue / Employee
n/a
Profits / Employee
-$2,433,579
Market Cap
27.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 2 | 5.56% | 38 | 0 |
| Dec 31, 2024 | 36 | 4 | 12.50% | 36 | 0 |
| Dec 31, 2023 | 32 | 11 | 52.38% | 32 | 0 |
| Dec 31, 2022 | 21 | -34 | -61.82% | 21 | 0 |
| Dec 31, 2021 | 55 | 17 | 44.74% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
IRLA News
- 3 days ago - Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - GlobeNewsWire
- 6 days ago - Quince Therapeutics Transcript: EGM 2026 - Transcripts
- 10 days ago - Quince Therapeutics Proxy statement: Proxy filing - Filings
- 13 days ago - Quince Therapeutics Transcript: KOL event - Transcripts
- 13 days ago - Quince Therapeutics Press release: KOL event - Filings
- 25 days ago - Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026 - GlobeNewsWire
- 4 weeks ago - Quince Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - Quince Therapeutics to Participate in September 2026 Investor Conferences - GlobeNewsWire